Obstructive sleep apnoea, type 2 diabetes and cardiovascular risk factors

2017 ◽  
Vol 39 ◽  
pp. e16-e17 ◽  
Author(s):  
B. De Vega Sánchez ◽  
S.A. Juarros Martínez ◽  
Milagros Del Olmo Chiches ◽  
C. Disdier Vicente ◽  
E. González Sarmiento
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factors ◽  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Obstructive Sleep

scholarly journals Morbidity and mortality in patients with cardiovascular risk factors and obstructive sleep apnoea: results from the DIAST-CHF cohort

2019 ◽  
Vol 154 ◽  
pp. 127-132 ◽  
Author(s):  
Helge Haarmann ◽  
Jennifer Koch ◽  
Nina Bonsch ◽  
Meinhard Mende ◽  
Stefanie Maria Werhahn ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factors ◽  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Morbidity And Mortality ◽  
Obstructive Sleep

scholarly journals Cardiovascular risk factors in men and women with obstructive sleep apnoea syndrome

2010 ◽  
Vol 104 (7) ◽  
pp. 1063-1068 ◽  
Author(s):  
Jean-Pierre Laaban ◽  
Line Mounier ◽  
Olivier Roque d'Orbcastel ◽  
Dan Veale ◽  
Jacques Blacher ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factors ◽  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Obstructive Sleep Apnoea Syndrome ◽  
Men And Women ◽  
Sleep Apnoea Syndrome ◽  
Obstructive Sleep

Obstructive Sleep Apnoea and Vascular Disease in Patients with Type 2 Diabetes

2015 ◽  
Vol 11 (02) ◽  
pp. 110
Author(s):  
Abd A Tahrani ◽  
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Vascular Disease ◽  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Vascular Risk Factors ◽  
Vascular Risk ◽  
Obstructive Sleep ◽  
The Impact

Obstructive sleep apnoea (OSA) is common and is associated with many vascular risk factors, such as hypertension, insulin resistance, albuminuria, dyslipidaemia, increased inflammation and endothelial dysfunction. Epidemiological studies have shown that OSA is associated with increased cardiovascular disease (CVD) and that continuous positive airway pressure (CPAP) might reduce CVD events in patients with OSA. In addition, OSA has also been shown to be associated with albuminuria, chronic kidney disease, a wide range of ocular diseases and peripheral neuropathy. Considering that CVD and microvascular complications are major contributors to the morbidity, mortality and the economic burden of diabetes and that OSA is common in patients with type 2 diabetes (T2D), it is important to understand the role of OSA in the development and/or progression of vascular disease in patients with T2D and to explore the impact of CPAP on diabetes-related vascular outcomes. The purpose of this article is to review the evidence for the relationship and impact of OSA on vascular disease and vascular risk factors particularly in patients with T2D.

scholarly journals Coexistence of cardiovascular risk factors and obstructive sleep apnoea in polysomnography

2021 ◽  
pp. 103782
Author(s):  
Paweł Gać ◽  
Dominika Urbanik ◽  
Piotr Macek ◽  
Helena Martynowicz ◽  
Grzegorz Mazur ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factors ◽  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Obstructive Sleep

scholarly journals Validation of the STOP-Bang questionnaire as a screening tool for obstructive sleep apnoea in patients with cardiovascular risk factors: a systematic review and meta-analysis

2021 ◽  
Vol 8 (1) ◽  
pp. e000848
Author(s):  
Mark Hwang ◽  
Kevin Zhang ◽  
Mahesh Nagappa ◽  
Aparna Saripella ◽  
Marina Englesakis ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cardiovascular Risk ◽  
Cardiovascular Risk Factors ◽  
Obstructive Sleep Apnoea ◽  
Screening Tool ◽  
Meta Analysis ◽  
Sleep Apnoea ◽  
Inclusion Criteria ◽  
Predictive Parameters ◽  
Obstructive Sleep

IntroductionObstructive sleep apnoea (OSA) is highly prevalent in patients with cardiovascular risk factors and is associated with increased morbidity and mortality. This review presents the predictive parameters of the STOP-Bang questionnaire as a screening tool for OSA in this population.MethodsA search of databases was performed. The inclusion criteria were: (1) use of the STOP-Bang questionnaire to screen for OSA in adults (>18 years) with cardiovascular risk factors; (2) polysomnography or home sleep apnoea testing performed as a reference standard; (3) OSA defined by either Apnoea–Hypopnoea Index (AHI) or Respiratory Disturbance Index; and (4) data on predictive parameters of the STOP-Bang questionnaire. A random-effects model was used to obtain pooled predictive parameters of the STOP-Bang questionnaire.ResultsThe literature search resulted in 3888 articles, of which 9 papers met the inclusion criteria, involving 1894 patients. The average age of the included patients was 58±13 years with body mass index (BMI) of 30±6 kg/m2, and 64% were male. The STOP-Bang questionnaire has a sensitivity of 89.1%, 90.7% and 93.9% to screen for all (AHI ≥5), moderate-to-severe (AHI ≥15) and severe (AHI≥30) OSA, respectively. The specificity was 32.3%, 22.5% and 18.3% and the area under the curve (AUC) was 0.86, 0.65 and 0.52 for all, moderate-to-severe and severe OSA, respectively.ConclusionThe STOP-Bang questionnaire is an effective tool to screen for OSA (AHI≥5) with AUC of 0.86 in patients with cardiovascular risk factors.

scholarly journals Obstructive Sleep Apnoea and Vascular Disease in Patients with Type 2 Diabetes

2015 ◽  
Vol 11 (2) ◽  
pp. 81 ◽  
Author(s):  
Abd A Tahrani ◽  
Keyword(s):  
Risk Factors ◽  
Type 2 Diabetes ◽  
Vascular Disease ◽  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Vascular Risk Factors ◽  
Vascular Risk ◽  
Obstructive Sleep ◽  
The Impact

Obstructive sleep apnoea (OSA) is common and is associated with many vascular risk factors, such as hypertension, insulin resistance, albuminuria, dyslipidaemia, increased inflammation and endothelial dysfunction. Epidemiological studies have shown that OSA is associated with increased cardiovascular disease (CVD) and that continuous positive airway pressure (CPAP) might reduce CVD events in patients with OSA. In addition, OSA has also been shown to be associated with albuminuria, chronic kidney disease, a wide range of ocular diseases and peripheral neuropathy. Considering that CVD and microvascular complications are major contributors to the morbidity, mortality and the economic burden of diabetes and that OSA is common in patients with type 2 diabetes (T2D), it is important to understand the role of OSA in the development and/or progression of vascular disease in patients with T2D and to explore the impact of CPAP on diabetes-related vascular outcomes. The purpose of this article is to review the evidence for the relationship and impact of OSA on vascular disease and vascular risk factors particularly in patients with T2D.

scholarly journals Obstructive sleep apnoea, incident type 2 diabetes mellitus, and cardiovascular risk

2015 ◽  
Author(s):  
N Munoz-Rivas ◽  
M Mendez-Bailon ◽  
M J Buendia ◽  
Canizo-Gomez F J del ◽  
A Partido ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Cardiovascular Risk ◽  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Incident Type ◽  
Obstructive Sleep ◽  
Incident Type 2 Diabetes
Sign in / Sign up

Export Citation Format

Share Document